9 stories mentioning ICUIUpdated 22d ago
Every FINWIRES story that references ICUI, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Brian Michael Bonnell, Chief Financial Officer, on September 01, 2026, sold 6,381 shares in ICU Medical (ICUI) for $1,116,675. Following the Form 4 filing with the SEC, Bonnell has control over a total of 56,062 common shares of the company, with 56,062 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000180483126000006/xslF345X05/edgardoc.xml
Brian Michael Bonnell, Chief Financial Officer, on August 31, 2026, sold 9,307 shares in ICU Medical (ICUI) for $1,608,143. Following the Form 4 filing with the SEC, Bonnell has control over a total of 62,443 common shares of the company, with 62,443 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000180483126000005/xslF345X05/edgardoc.xml
Ben Sousa, Chief Information Officer, on August 12, 2026, sold 2,250 shares in Icu Medical (ICUI) for $401,209. Following the Form 4 filing with the SEC, Sousa has control over a total of 3,076 shares of the company, with 3,076 common shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000201341226000003/xslF345X05/edgardoc.xml
Christian B. Voigtlander, Chief Operating Officer, on August 11, 2026, sold 8,929 shares in ICU Medical (ICUI) for $1,633,404. Following the Form 4 filing with the SEC, Voigtlander has control over a total of 37,377 common shares of the company, with 37,377 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000172747726000003/xslF345X05/edgardoc.xml
ICU Medical (ICUI) has an average rating of buy and mean price target of $171.71, according to analysts polled by FactSet.
ICU Medical (ICUI) shares rose 3.3% in Wednesday trading after Needham upgraded the stock to buy from hold with a price target of $165.Intraday volume topped 196,157 shares, compared with the daily average of 287,963.Price: $139.42, Change: $+4.45, Percent Change: +3.30%
ICU Medical (ICUI) has an average rating of buy and mean price target of $172, according to analysts polled by FactSet.
Daniel Woolson, President, on May 22, 2026, sold 2,123 shares in Icu Medical Inc/de (ICUI) for $280,685. Following the Form 4 filing with the SEC, Woolson has control over a total of 22,479 common shares of the company, with 22,479 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000169899826000003/xslF345X05/primary_doc.xmlPrice: $133.19, Change: $+1.88, Percent Change: +1.43%
David C. Greenberg, Director, on May 13, 2026, sold 2,424 shares in Icu Medical (ICUI) for $297,934. Following the Form 4 filing with the SEC, Greenberg has control over a total of 9,214 common shares of the company, with 9,214 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/883984/000164586626000001/xslF345X05/primary_doc.xml
